Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 47: 1443-1450, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seibel, M. J.
Right arrow Articles by Geilenkeuser, W.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seibel, M. J.
Right arrow Articles by Geilenkeuser, W.-J.
Related Collections
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2001;47:1443-1450.)
© 2001 American Association for Clinical Chemistry, Inc.

Articles

Interlaboratory Variation of Biochemical Markers of Bone Turnover

Markus J. Seibel1a, Matthias Lang1 and Wolf-Jochen Geilenkeuser2

1 Department of Medicine, University of Heidelberg, Bergheimerstrasse 58, D-69115 Heidelberg, Germany.
2 Institute for Clinical Biochemistry, University of Bonn, D-53127 Bonn, Germany

aAuthor for correspondence. Fax 49-6221-564101; e-mail Markus_Seibel{at}med.uni-heidelberg.de.

Background: Biochemical markers of bone metabolism are used to assess skeletal turnover, but the variability of marker assays is still an issue of practical concern. We describe the results of an international proficiency testing program for biochemical bone markers among clinical laboratories.

Methods: Two serum and two urine pools (normal and increased marker concentrations) were sent on dry ice to 79 laboratories for analysis within 2 weeks of receipt.

Results: Data were submitted by 73 laboratories. The within-method interlaboratory CVs (CVILs) were as follows: serum bone-specific alkaline phosphatase (n = 47 laboratories), 16–48%; serum osteocalcin (n = 31), 16–42%; urinary free deoxypyridinoline (n = 30), 6.4–12%; urinary total deoxypyridinoline and pyridinoline (n = 29), 27–28%; urinary N-terminal cross-linked telopeptide of type I collagen (n = 10), 39%; serum C-terminal cross-linked telopeptide of type I collagen (ICTP; n = 8), 22–27%; urinary hydroxyproline (n = 13), 12%. Analytical results showed both systematic and nonsystematic deviations. In identical samples, results obtained for the same marker by the same method differed up to 7.3-fold. In urine-based assays, correction for urinary creatinine slightly increased CVs.

Conclusion: Even with identical assays and methods, results for most biochemical markers of bone turnover differ markedly among laboratories.




The following articles in journals at HighWire Press have cited this article:


Home page
 JBJSHome page
A. Unnanuntana, B. P. Gladnick, E. Donnelly, and J. M. Lane
The Assessment of Fracture Risk
J. Bone Joint Surg. Am., March 1, 2010; 92(3): 743 - 753.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. E. Kraenzlin, C. A. Kraenzlin, C. Meier, C. Giunta, and B. Steinmann
Automated HPLC Assay for Urinary Collagen Cross-links: Effect of Age, Menopause, and Metabolic Bone Diseases
Clin. Chem., September 1, 2008; 54(9): 1546 - 1553.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Kleerekoper
Biochemical Markers of Bone Turnover: Why Theory, Research, and Clinical Practice Are Still in Conflict
Clin. Chem., August 1, 2001; 47(8): 1347 - 1349.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.